In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
about
Carbapenems: past, present, and futureSynergy among antibacterial peptides and between peptides and small-molecule antibiotics.Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.Acinetobacter baumannii: emergence of a successful pathogenGlobal challenge of multidrug-resistant Acinetobacter baumanniiThe role of carbapenems in initial therapy for serious Gram-negative infections.Disruption of Membrane by Colistin Kills Uropathogenic Escherichia coli Persisters and Enhances Killing of Other AntibioticsNew information about the polymyxin/colistin class of antibiotics.Rifampin combination therapy for nonmycobacterial infections.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenemsIn Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniaeSynergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii.Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii.In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.Serovars of Leptospira isolated from dogs and rodents.In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China.
P2860
Q24634999-8A84B3AA-EFCC-4C80-B63A-99B89412664AQ33593511-DFF87F08-70AF-43E0-AA47-06F83223035AQ34309445-318AB54A-103D-450D-8DAE-D6F41ABAC997Q34795807-8221C564-5957-476C-BDBC-9CC65C91F0D9Q36095081-279C0F9A-54B3-4AC8-9DC7-9B33EA3B9FB1Q37169849-88CBF7F3-E1CE-4A11-9BB9-ACD8AE227343Q37358713-B4808BCC-3FFD-4A9D-88EE-09756CA16667Q37636150-459B039F-19E6-4B19-811D-1614528FDBFCQ37672039-D5D70E34-872E-4AB3-8CD2-5484839AFB08Q37869910-8C032EDC-F706-44C2-862D-8B1E6CD3B4B6Q38126768-42229B25-FF04-4EF7-849C-C0BEFFCA666DQ40855475-49049BF3-C0C2-43CB-816F-0C88F6C4F987Q40936660-762BE7D9-1241-4BDB-B202-AD9EACB0836CQ41827843-B8295CC2-567B-41C1-A1A4-2966963CC7C3Q41936281-8789BCE3-9ADC-4D27-A687-E556394508DBQ42011492-E45DC132-7596-46DD-8D7E-495FF0E3F957Q42021167-662973CF-07A7-4FD8-A089-ABF6A3BCB754Q42050464-92E935C0-C382-41F2-9F4F-BCB444F8BDE6Q42239726-83A68AC3-4968-4C9F-8541-F3A622B6E267Q43870052-E803E02C-330C-40E6-8703-CDCAED597605Q44856016-A4133EA2-E2AF-4896-9FD0-9999A8216870Q54275190-E6CDAFF1-6ED8-444D-8F5B-5A93189F39EBQ55266483-5D4BDBB3-8B82-493E-AE8C-44DAAA119E1C
P2860
In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
In-vitro activity of polymyxin ...... oducing OXA-23 carbapenemases.
@en
type
label
In-vitro activity of polymyxin ...... oducing OXA-23 carbapenemases.
@en
prefLabel
In-vitro activity of polymyxin ...... oducing OXA-23 carbapenemases.
@en
P2860
P921
P356
P1476
In-vitro activity of polymyxin ...... oducing OXA-23 carbapenemases.
@en
P2093
David C Bean
P2860
P2888
P356
10.1186/1476-0711-5-10
P577
2006-04-21T00:00:00Z
P5875
P6179
1033019727